202610.23
37

False Urgency, Fatal Suppression: Delhi High Court Vacates NUREWIRE Injunction

The Delhi High Court Division Bench, in an appeal against an ex-parte ad-interim injunction granted by a learned Single Judge, vacated the injunction in a trademark dispute involving NUREWIRE and RewireX, used for nutraceutical products. The Bench found that the Plaintiff had wilfully suppressed material facts concerning its prior knowledge of the Defendants’ adoption of…

202610.13
37

When a Franchise Ends but Brand Association Lingers: Bombay High Court Restrains ‘KIDGEE’ Use After ‘KIDZEE’ Franchise

The Bombay High Court, in proceedings under Section 9 of the Arbitration and Conciliation Act, 1996, has restrained a former franchisee from using “KIDZEE”, “KIDGEE” or any deceptively or phonetically similar name after the expiry of her franchise agreement with Zee Learn Limited. The Court held that regulatory permission to operate a school under a…

202610.12
37

Synthetic Content in Advertising: ASCI’s New Labelling Guidelines

Artificial intelligence is increasingly used in advertising to edit content, create virtual influencers and synthetic voices, personalise messaging, and produce realistic product demonstrations. As AI-generated content becomes more sophisticated, consumers may find it difficult to distinguish between authentic depictions and content that has been generated or materially altered using AI. When does AI-generated content need…

202610.01
38

India’s revised film-certification guidelines: new warning requirement for drug-related scenes

India’s revised film-certification guidelines largely preserve the existing certification framework, but one change is likely to matter in practice: scenes involving narcotic drugs or psychotropic substances must now carry a prescribed statutory warning. For filmmakers and producers, the point is not merely editorial. Drug-related scenes may now require early compliance review during scripting, editing and…